NiPPeR Child: NiPPeR Randomised Trial - Child Follow Up Study

Sponsor
University of Southampton (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05934422
Collaborator
National University Hospital, Singapore (Other), Auckland UniServices Ltd. (Industry), Singapore Institute for Clinical Sciences (Other), National University of Singapore (Other), National University Health System, Singapore (Other), University of Auckland, New Zealand (Other)
510
3
2
38.5
170
4.4

Study Details

Study Description

Brief Summary

There is an increasing focus on the need to optimise nutrition, lifestyle and metabolism of parents before and during pregnancy and of the infant after birth, but as yet there is limited understanding of the specific influences and of the underlying mechanisms.

This study is a follow up of children from the NiPPeR trial of a nutritional drink enriched with micronutrients, myo-inositol and probiotics taken preconception and during pregnancy. In this setting we will examine the influence of parental nutrition, lifestyle and metabolism before and during pregnancy on child growth, development and well-being; ascertaining growth, adiposity, metabolism, neurobehavioural and health outcomes in the children, and characterising the underlying mechanisms.

The data collected will allow identification of the contributions of parental and offspring characteristics, nutritional, lifestyle and medical factors, social and economic status, ethnicity, genetics, metabolism and microbes to promoting healthy growth, body composition and wellbeing in the children.

Condition or Disease Intervention/Treatment Phase
  • Other: Intervention (Study Nutritional Drink)
  • Other: Control (Standard Nutritional Drink)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
510 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Nutritional Intervention Preconception and During Pregnancy to Maintain Healthy Glucose Metabolism and Offspring Health - Child Health and Well-being Follow Up Study
Actual Study Start Date :
Jun 16, 2023
Anticipated Primary Completion Date :
Aug 30, 2026
Anticipated Study Completion Date :
Aug 30, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prior Intervention - enhanced micronutrients, probiotics, myo-inositol in preconception & pregnancy

NiPPeR Study intervention drink containing a mix of micronutrients, probiotics and myo-inositol given to the mother during preconception & pregnancy

Other: Intervention (Study Nutritional Drink)
Study nutritional drink containing a mix of enriched micronutrients, probiotics and myo-inositol.

Active Comparator: Prior Control - standard micronutrients in preconception & pregnancy

NiPPeR Study control nutritional drink containing a mix of micronutrients given to the mother during preconception & pregnancy

Other: Control (Standard Nutritional Drink)
Control nutritional drink containing a standard mix of micronutrients

Outcome Measures

Primary Outcome Measures

  1. Child Body Mass Index (kg/m2), derived from weight and height [Up to age 8 years, from periconception to age 8 years]

    Child size and body composition

  2. Intellectual function (WASI-II IQ [4 sub-test scores], higher score is a higher IQ) [Up to age 8 years, from periconception to age 8 years]

    Child cognition

  3. Child insulin resistance (HOMA2-IR [no units], higher value is greater insulin resistance) [Up to age 8 years, from periconception to age 8 years]

    Child insulin resistance

  4. Dimensional Change Card Sort Test (raw & T-scores) [Up to age 8 years, from periconception to age 8 years]

    Child executive functioning - NIH Toolbox Cognition Battery component

  5. Flanker Inhibitory Control & Attention Test (raw & T-scores) [Up to age 8 years, from periconception to age 8 years]

    Child executive functioning - NIH Toolbox Cognition Battery Component

  6. Strengths & Difficulties Questionnaire score (no units) [Up to age 8 years, from periconception to age 8 years]

    Child neurobehavioural functioning

  7. Child Behaviour Check List score (no units) [Up to age 8 years, from periconception to age 8 years]

    Child neurobehavioural functioning

Secondary Outcome Measures

  1. Body fat mass (kg, % and indices) [Up to age 8 years, from periconception to age 8 years]

    Obesity and body composition

  2. Change in body fat mass (kg) [Up to age 8 years, from periconception to age 8 years]

    Adiposity gain

  3. Body lean mass (kg, % and indices) [Up to age 8 years, from periconception to age 8 years]

    Child body composition - lean mass

  4. Change in lean mass (kg) [Up to age 8 years, from periconception to age 8 years]

    Lean mass gain

  5. Body bone mass (kg, % and indices) [Up to age 8 years, from periconception to age 8 years]

    Child body composition - bone mass

  6. Change in bone mass (kg) [Up to age 8 years, from periconception to age 8 years]

    Bone mass gain

  7. Child height (cm) [Up to age 8 years, from periconception to age 8 years]

    Child height

  8. Height growth (cm) [Up to age 8 years, from periconception to age 8 years]

    Linear growth

  9. Change in body mass index (z-score & percentile) [Up to age 8 years, from periconception to age 8 years]

    Change in BMI

  10. Change in weight (kg) [Up to age 8 years, from periconception to age 8 years]

    Weight gain

  11. Child mid-upper arm circumference (cm) [Up to age 8 years, from periconception to age 8 years]

    Child arm circumference

  12. Change in mid-upper circumference (z-score) [Up to age 8 years, from periconception to age 8 years]

    Change in soft tissue mass

  13. Child waist circumference (cm) [Up to age 8 years, from periconception to age 8 years]

    Child waist circumference

  14. Change in waist circumference (z-score) [Up to age 8 years, from periconception to age 8 years]

    Adiposity gain

  15. Heart rate response to step test (beats per minute) [Up to age 8 years, from periconception to age 8 years]

    Cardiovascular fitness and function

  16. Child blood pressure (mm Hg) [Up to age 8 years, from periconception to age 8 years]

    Cardiovascular fitness and function

  17. Child resting heart rate (beats per minute) [Up to age 8 years, from periconception to age 8 years]

    Cardiovascular fitness and function

  18. Child minutes to return to resting heart rate (minutes) [Up to age 8 years, from periconception to age 8 years]

    Cardiovascular fitness and function

  19. Diagnosed medical conditions or disorders ascertained by questionnaire, including child medical conditions, infections, gastrointestinal, cardiovascular, respiratory, dermatological, neuropsychological, mental and musculoskeletal health and wellbeing [Up to age 8 years, from periconception to age 8 years]

    Child health and wellbeing

  20. Dietary patterns ascertained by frequency questionnaires [Up to age 8 years, from periconception to age 8 years]

    Child diet

  21. Child Eating Behaviour Questionnaire [Up to age 8 years, from periconception to age 8 years]

    Child eating behaviours

  22. Parental Feeding Practices Questionnaire [Up to age 8 years, from periconception to age 8 years]

    Parental feeding practices

  23. Children's Sleep Habits Questionnaire [Up to age 8 years, from periconception to age 8 years]

    Child sleep patterns

  24. Children's actigraphy measurements of activity behaviours [minutes/day] [Up to age 8 years, from periconception to age 8 years]

    Child physical activity, sleep and sedentary behaviours

  25. Child Movement Behaviour Questionnaire [Up to age 8 years, from periconception to age 8 years]

    Child activity behaviours

  26. Skin pricks test results to allergens [mm] [Up to age 8 years, from periconception to age 8 years]

    Child atopic sensitisation

  27. Child asthma, wheezing illnesses, eczema, rhinitis and food allergy by clinical examination & questionnaires [Up to age 8 years, from periconception to age 8 years]

    Child atopic and allergic wellbeing and disorders

  28. Hair metabolome panel concentrations (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Biomarkers of health and wellbeing measured in hair samples

  29. Urine micronutrient concentrations (nmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child micronutrient status

  30. Blood micronutrient concentrations (nmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child circulating micronutrient profile

  31. Blood trace element concentrations (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child circulating trace element profile

  32. Urine trace element concentrations (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child trace element status

  33. Stool metagenomic profile (abundance) [Up to age 8 years, from periconception to age 8 years]

    Child gut microbiota composition

  34. Skin metagenomic profile (abundance) [Up to age 8 years, from periconception to age 8 years]

    Child skin microbiota composition

  35. Stool metatranscriptomic profile (relative activity) [Up to age 8 years, from periconception to age 8 years]

    Child gut microbiota activity profile

  36. Skin metatranscriptomic profile (relative activity) [Up to age 8 years, from periconception to age 8 years]

    Child skin microbiota activity profile

  37. Stool metabolomic profile (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child gut microbiota metabolite profile

  38. Skin metabolomic profile (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child skin microbiota metabolite profile

  39. Blood molecular profile (% methylation) [Up to age 8 years, from periconception to age 8 years]

    Child blood epigenetic profile

  40. Buccal molecular profile (% methylation) [Up to age 8 years, from periconception to age 8 years]

    Child buccal cell epigenetic profile

  41. Blood transcriptomic profile (relative expression) [Up to age 8 years, from periconception to age 8 years]

    Child blood transcriptomic profile

  42. Buccal transcriptomic profile (relative expression) [Up to age 8 years, from periconception to age 8 years]

    Child buccal cell transcriptomic profile

  43. Genetic variation (DNA sequence analysis) [Up to age 8 years, from periconception to age 8 years]

    Genetic variant analysis

  44. Circulating chemocytokine measurements (nmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child chemocytokine profile

  45. Circulating adipokine measurements (nmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child adipokine profile

  46. Circulating inflammatory marker measurement (nmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child inflammatory factor profile

  47. Plasma glucose concentration (mmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child's plasma glycemia

  48. Plasma lipid concentrations (mmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child's metabolic profile - lipid concentrations

  49. Plasma high-sensitivity C-reactive protein concentrations (mmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child's inflammatory marker status

  50. Blood metabolome panel concentrations (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child's blood metabolomic status

  51. Urine metabolome panel concentrations (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Child's urine metabolomic status

  52. Urine measurement of environmental pollutant exposure (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Urine exposome pollutant profile

  53. Blood measurement of environmental pollutant exposure (ng/gm lipid) [Up to age 8 years, from periconception to age 8 years]

    Blood exposome pollutant profile

  54. Hair measurement of environmental pollutant exposure (pmol/L) [Up to age 8 years, from periconception to age 8 years]

    Hair exposome pollutant profile

Other Outcome Measures

  1. Healthcare utilisation (US$) [Up to age 8 years, from periconception to age 8 years]

    Health economics analysis of child outcomes

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 8 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

All children still participating in the NiPPeR study at 6-8 years.

Exclusion Criteria:

Known significant congenital anomaly or genetic condition that influences child growth or neurodevelopment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The University of Auckland Auckland New Zealand 1142
2 National University Hospital Singapore Singapore 119228
3 University Hospital Southampton Southampton Hampshire United Kingdom SO16 6YD

Sponsors and Collaborators

  • University of Southampton
  • National University Hospital, Singapore
  • Auckland UniServices Ltd.
  • Singapore Institute for Clinical Sciences
  • National University of Singapore
  • National University Health System, Singapore
  • University of Auckland, New Zealand

Investigators

  • Principal Investigator: Wayne S Cutfield, MB MD FRACP, The University of Auckland
  • Principal Investigator: Shiao-Yng Chan, MD PhD FRCOG, National University of Singapore
  • Principal Investigator: Keith M Godfrey, BM PhD FRCP, MRC Lifecourse Epidemiology Centre, University of Southampton

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of Southampton
ClinicalTrials.gov Identifier:
NCT05934422
Other Study ID Numbers:
  • 79093
First Posted:
Jul 7, 2023
Last Update Posted:
Jul 7, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Southampton
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2023